Radiation-induced HMGB1 release from dying cells activates Toll-like receptor 4 (TLR4)-dependent DCs, which in turn mediate a cytotoxic T-lymphocyte (CTL) response against tumor cells [67]. The gene discussed is TLR4; the disease is neoplasm.